HSBC MSCI Pacific ex Japan UCITS ETF USD is a equity ETF from HSBC tracking the MSCI Pacific ex Japan index through physical replication. Domiciled in Ireland and launched in 2010, the fund manages about 672 M € and charges a TER of 0.15% — 15 € per year on a €10,000 investment. Income is paid out to investors periodically (distributing).
HSBC MSCI Pacific ex Japan UCITS ETF USD competes with 2 other products on the same index (MSCI Pacific ex Japan): it ranks 2nd by fund size and 1st by ongoing cost, with a TER of 0.15% against a group median of 0.20%. It has been listed since 2010, 16 years of track record — the oldest in its comparison group.
On a €10,000 investment the TER costs 15 € a year, and no product in the group costs less.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 45.5% of the portfolio.
Income is distributed periodically: it produces cash flow, but reinvesting it is up to you if the goal is capital growth. The fund is denominated in USD. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
The fund is domiciled in Ireland, which determines the tax treatment of income received by the fund and the supervisory authority.
| Commonwealth Bank of Australia | 8.5% |
| BHP Group Ltd | 7.3% |
| AIA Group Ltd | 5.1% |
| DBS Group Holdings Ltd | 4.4% |
| Westpac Banking Corporation | 4.2% |
| National Australia Bank Ltd | 4.1% |
| ANZ Group Holdings Ltd | 3.4% |
| Hong Kong Exchange and Clearing Ltd | 3.0% |
| Wesfarmers Ltd | 2.9% |
| CSL Ltd | 2.6% |
| Borsa Italiana | HMXJ | EUR |
| Francoforte | H4ZH | EUR |
| London Stock Exchange | HMXJ | GBX |
| London Stock Exchange | HMXD | USD |
| Euronext Paris | MXJ | EUR |
| SIX Swiss Exchange | HMXJ | USD |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.